Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge
On August 22, Paragonix Technologies announced that it entered into a definitive agreement to be acquired by Getinge for an undisclosed price. Paragonix Technologies, headquartered in Waltham, Massachusetts, is a developer and manufacturer in the organ transplant industry. In March 2023, Paragonix partnered with Signet Healthcare Partners, a New York-based private equity firm, to support the company’s growth and strategic objectives. Founded in Sweden in 1904, Getinge is a global medical technology company that provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. Getinge employs approximately 12,000 people... Read More »LetsGetChecked Acquires Truepill
LetsGetChecked (LGC), which is based in Dublin, Ireland and New York, New York, announced the acquisition of Truepill for $25 million. Founded in 2016, Truepill’s business-to-business solutions include its virtual pharmacy digital experience, patient services to drive adherence, engagement, quality and performance and nationwide prescription fulfillment. Truepill had raised more than $370 million in venture capital funding, including at a $1.6 billion valuation in 2021, from firms like Optum, Optum Ventures, Oak HC/FT and Initialized Capital. LGC is a leading healthcare solutions company that allows customers to manage their health from home, providing direct access to... Read More »
Walgreens Inks $100M Deal to Boost Clinical Trials
Walgreens Boots Alliance Inc. is teaming up with the U.S. government to revolutionize clinical trials. The pharmacy giant has secured a $100 million deal to expand its decentralized clinical trial platform, aiming to make research more accessible and inclusive. Walgreens’ decentralized clinical trial platform offers several advantages for both patients and researchers. For patients, it provides greater flexibility and convenience by allowing them to participate in trials closer to their homes and on their own schedules. This can help to increase enrollment rates, especially among underserved populations. For researchers, the platform streamlines the trial process by automating tasks... Read More »
Moses/Weitzman Health System Acquires Waterbury, Connecticut MOB
Belfonti Companies LLC announced that it sold a Waterbury, Connecticut medical outpatient building (MOB) for $2.9 million. The buyer was The Moses/Weitzman Health System. The transaction closed on July 31, 2024 and was announced on August 13, 2024. The MOB consists of 15,520 square feet and is situated on more than 1.6 acres of land, according to property records. It is occupied by the Community Health Center of Waterbury. The price was approximately $187 per square foot. Belfonti is a real estate developer that acquires, develops, renovates and manages value-added real estate development and investment assets throughout the United States and abroad. The company is based in... Read More »
